Appendix 4C

+Rule 4.7B

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity BIOTRON LIMITED ABN Quarter ended ("current quarter") 60 086 399 144 31 December 2016 Consolidated statement of cash flows Currentquarter $A'000
  1. Cash flows from operating activities Year to date (6 months) $A'000

    1. Receipts from customers

    2. Payments for

      1. research and development

      2. product manufacturing and operating

        - -

        (431) (1,236)

        costs - -

      3. advertising and marketing

      4. leased assets - -

      5. staff costs (187) (378)

      6. administration and corporate costs (264) (442)

      7. Dividends received (see note 3) - -

      8. Interest received 7 18

      9. Interest and other costs of finance paid - -

      10. Income taxes paid - -

      11. Government grants and tax incentives - -

      12. Other (reimbursement of expenses) 23 38

        1.9 Net cash from / (used in) operating

        activities (852) (2,000)

      13. Cash flows from investing activities

        1. Payments to acquire:

          1. property, plant and equipment - -

          2. businesses (see item 10) - -

          3. investments - -

            Consolidated statement of cash flows Currentquarter $A'000 Year to date (6 months) $A'000

          4. intellectual property - -

          5. other non-current assets - -

          6. Proceeds from disposal of:

            1. property, plant and equipment - -

            2. businesses (see item 10) - -

            3. investments - -

            4. intellectual property - -

            5. other non-current assets - -

            6. Cash flows from loans to other entities - -

            7. Dividends received (see note 3) - -

            8. Other (provide details if material) - -

              2.6 Net cash from / (used in) investing activities --
            9. Cash flows from financing activities

              1. Proceeds from issues of shares - -

              2. Proceeds from issue of convertible notes - -

              3. Proceeds from exercise of share options - 8

              4. Transaction costs related to issues of

                shares, convertible notes or options - -

              5. Proceeds from borrowings - -

              6. Repayment of borrowings - -

              7. Transaction costs related to loans and

                borrowings - -

              8. Dividends paid - -

              9. Other (provide details if material) - -

                3.10 Net cash from / (used in) financing activities -8
              10. Net increase / (decrease) in cash and cash equivalents for the period

                1. Cash and cash equivalents at beginning of quarter/year to date

                2. Net cash from / (used in) operating

                  2,278 3,418

                  activities (item 1.9 above) (852) (2,000)

                3. Net cash from / (used in) investing activities

                  (item 2.6 above) - -

                4. Net cash from / (used in) financing activities

                  (item 3.10 above) - 8

                  Consolidated statement of cash flows Currentquarter $A'000

                5. Effect of movement in exchange rates on

                  Year to date (6 months) $A'000

                  cash held - -

                  4.6 Cash and cash equivalents at end of

                  quarter 1,426 1,426

                6. Reconciliation of cash and cash equivalents

                  at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

                  Current quarter $A'000 Previous quarter $A'000

                  1. Bank balances 1,426 2,278

                  2. Call deposits - -

                  3. Bank overdrafts - -

                  4. Other (provide details) - -

                    5.5 Cash and cash equivalents at end of quarter (should equal item 4.6 above) 1,4262,278
                  5. Payments to directors of the entity and their associates Currentquarter $A'000

                    1. Aggregate amount of payments to these parties included in item 1.2 131

                    2. Aggregate amount of cash flow from loans to these parties included

                      in item 2.3 -

                    3. Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

                      N/A

                    4. Payments to related entities of the entity and their associates Current quarter $A'000

                      1. Aggregate amount of payments to these parties included in item 1.2 55

                      2. Aggregate amount of cash flow from loans to these parties included

                        in item 2.3 -

                      3. Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

                        N/A

                      4. Financing facilities available Add notes as necessary for an understanding of the position Total facility amount at quarter end $A'000 Amount drawn at quarter end $A'000

                        1. Loan facilities - -

                        2. Credit standby arrangements - -

                        3. Other (please specify) - -

                        4. Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

                          5. N/A

                          9.

                          Estimated cash outflows for next quarter

                          $A'000

                          9.1

                          Research and development

                          550

                          9.2

                          Product manufacturing and operating costs

                          -

                          9.3

                          Advertising and marketing

                          -

                          9.4

                          Leased assets

                          -

                          9.5

                          Staff costs

                          191

                          9.6

                          Administration and corporate costs

                          170

                          9.7

                          Other (provide details if material)

                          -

                          9.8

                          Total estimated cash outflows

                          911

                          1. Acquisitions and disposals of business entities (items 2.1(b) and 2.2(b) above) Acquisitions Disposals

                            1. Name of entity - -

                            2. Place of incorporation or

                              registration - -

                            3. Consideration for acquisition or

                              disposal - -

                            4. Total net assets - -

                            5. Nature of business - -

                          Biotron Limited published this content on 16 January 2017 and is solely responsible for the information contained herein.
                          Distributed by Public, unedited and unaltered, on 16 January 2017 08:50:01 UTC.

                          Original documenthttp://www.biotron.com.au/wp-content/uploads/2017/01/Appendix-4C-Quarterly-Report.pdf

                          Public permalinkhttp://www.publicnow.com/view/21AD66656D38ADC542392E5CD12F682B223F4598